Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.
|
|
- Neil McCarthy
- 5 years ago
- Views:
Transcription
1 Valve Surgery Total Volume 1 1 Volume N = In 1, surgeons performed 339 valve surgeries. surgeons have implanted more than 1, bioprosthetic aortic valves since the 199s, with excellent short- and long-term outcomes. 3 Outcomes 1
2 Primary Operation and Reoperation Volume (N = 339) 1 Volume Primary Operation Reoperation N = 791 In 1, surgeons performed primary valve procedures and 791 valve reoperations. Primary Operation and Reoperation In-Hospital Mortality (N = 339) 1 Expected Primary Reoperation Operation N = 791 Patients who have valve surgery reoperations have a somewhat higher risk of death compared with patients who have a primary operation, due to the overall decrease in health over time. Despite this, the in-hospital mortality rates were lower than expected for both reoperations and primary procedures. Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Sydell and Arnold Miller Family Heart & Vascular Institute 33
3 In-Hospital Mortality by Procedure Type (N = 11) Surgical Isolated AVR Transcatheter AVR AVR + CABG Isolated MVR MVR + CABG Isolated MV Repair N = STS expected AVR = aortic valve replacement, CABG = coronary artery bypass graft, MV = mitral valve, MVR = mitral valve replacement surgeons performed a total of 339 valve surgeries in 1. However, the procedures included in this graph represent only those that are recognized by the Society of Thoracic Surgeons (STS). The mortality rates for valve surgery were lower than the STS-expected rates. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 1 Aortic Valve Surgery 1 1 Volume 5 15 In 1, 11 aortic valve procedures were performed at. 1 5 N = Outcomes 1 3
4 STS Rating for Aortic Valve Replacement July 13 June 1 ranked among the top % of US hospitals for aortic valve replacement (AVR) surgery, earning the Society of Thoracic Surgeons (STS) 3-star rating for this category. This denotes the highest category of quality. Participant Score (95% Confidence Interval) STS Mean Participant Score Participant Rating 97.5% 95.3% (9.9, 9.) STS Min. 1th 9.9 5th 9.7 9th 97.3 Max 9. = STS mean participant score Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 1 Isolated Aortic Valve Replacement Complications (N = 379) 1 1 STS expected Deep Sternal Wound Infection Postop Stroke Postop Renal Failure Postop Reoperation (Any) N = had lower-than-expected rates of complications for isolated aortic valve replacement surgery. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 1 Sydell and Arnold Miller Family Heart & Vascular Institute 35
5 STS Rating for Coronary Artery Bypass Graft and Aortic Valve Replacement July 13 June 1 is ranked among top US hospitals for coronary artery bypass graft (CABG) surgery plus aortic valve replacement (AVR), earning the Society of Thoracic Surgeons (STS) 3-star rating for this category (based on data from July 13 through June 1). This denotes the highest category of quality. Participant Score (95% Confidence Interval) STS Mean Participant Score Participant Rating 95.1% 9.% (9., 9.) STS Min 7. 1th. 5th 9. 9th 95. Max 97. = STS mean participant score Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 1 Combined AVR and CABG Surgery In-Hospital Mortality (N = 9) 1 1 N = Primary Operation Reoperation 7 STS expected Aortic valve replacement, in combination with CABG surgery, is a complex operation. Despite this complexity and the associated increase in risks, inhospital mortality rates for both primary operations and reoperations were low. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 1 3 Outcomes 1
6 Mitral Valve Surgery (N = 139) Volume, Repair vs Replacement Repair Replacement performs mitral valve repair procedures rather than replacement whenever possible. Mitral valve repair is possible for more than 95% of patients who have mitral valve prolapse. The procedure is associated with better survival, improved lifestyle, better preservation of heart function, and a lower risk of stroke and infection (endocarditis) compared with mitral valve replacement. Repair procedures also do not require postprocedure anticoagulation therapy. Isolated Mitral Valve Surgery In-Hospital Mortality (N = 39) 1 STS expected The 1 in-hospital mortality rates for patients who had isolated mitral valve surgery were lower than expected for both repair and replacement procedures. Replacement Repair N = 3 3 Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 1 Sydell and Arnold Miller Family Heart & Vascular Institute 37
7 Surgical Treatment of Active Infective Endocarditis Primary Operation, In-Hospital Mortality Observed Expected The in-hospital mortality rates for patients who had primary operations for infective endocarditis were lower than expected in 1. 5 N = Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Reoperation, In-Hospital Mortality Observed Expected The in-hospital mortality rates for patients who had reoperations for infective endocarditis were lower than expected in 1. 5 N = Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. 3 Outcomes 1
8 Transcatheter Aortic Valve Replacement is a national leader in the use of percutaneous treatment options for patients with valve disease. Volume and In-Hospital Mortality 1 1 Volume 3 Mortality (%) 1 1 Observed Expected N = N = A total of 37 patients had transcatheter aortic valve replacement procedures at in 1. The in-hospital mortality rate was % compared with an expected rate of.9%. The 3-day mortality rate was.3% (N = 1). Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Since the inception of the transcatheter aortic valve replacement (TAVR) program in, has become a world leader in the use of this specialized treatment in patients carefully selected based on stringent clinical criteria. A total of 139 patients have had this procedure done from 1 to 1. Source: STS/ACC TVT Registry Sydell and Arnold Miller Family Heart & Vascular Institute 39
9 Volume by Approach (N = 155) 1 1 Of the 155 TAVR procedures performed from 1 through 1, 77% have been done using a transfemoral approach. 1% 77% transfemoral (N = 97) 13% transapical (N = 13) % transaortic (N = 75) % other (transaxillary, transcarotid) (N = 3) % subclavian (N = ) Outcomes 1
Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.
Valve Surgery 11 15 Volume 3 1 11 1 13 1 N = 1 773 5 79 15 93 In 15, surgeons performed 93 valve surgeries. surgeons have implanted more than 1,5 bioprosthetic aortic valves since the 199s, with excellent
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationMechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute
Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Assistant Professor, Georgetown School of Medicine
More informationPolicy Specific Section: March 30, 2012 March 7, 2013
Medical Policy Transcatheter Aortic Valve Replacement for Aortic Stenosis Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date:
More informationAfter PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?
After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? Vinod H. Thourani, MD Professor of Surgery and Medicine Emory University Disclosure Statement of Financial
More informationIn 2015, Cleveland Clinic surgeons performed 1551 thoracic procedures. The in-hospital mortality rate was 2.1%. 20% airway (N = 315)
thoracic surgeons treat patients with a wide variety of diseases of the lung and esophagus. The staff is composed of specialists in lung and esophageal cancer, lung failure, airway disease, swallowing
More informationPeripheral Vascular Disease
Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of
More informationIn Process, Unpublished STS/ACC TVT Registry Manuscripts
In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript
More informationIn Process, Unpublished STS/ACC TVT Registry Manuscripts
In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript
More informationValvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD
Valvular Heart Disease Transcatheter Valve Therapies October 2016 Brian Whisenant MD Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationExtension to medium and low risk patients? Friedrich Eckstein University Hospital Basel
TAVI CON Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel Extension to medium and low risk patients? In octogenerians already reality in most of the swiss clinics!?
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationSotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.
CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director
More informationOutcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and
Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American
More informationTranscatheter Valve Replacement: Current State in 2017
Transcatheter Valve Replacement: Current State in 2017 Marc A. Sintek MD Assistant Professor of Medicine Interventional Cardiology Cardiovascular Division Washington University in St. Louis Missouri ACP
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Measure #165 (NQF 0130): Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationMitraClip: Why, How, and For Whom?
MitraClip: Why, How, and For Whom? Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief, JAMA Cardiology
More informationValvular Intervention
Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone
More informationObjectives. Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient
None Endorsements Objectives Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient Understand clinical and clinician benefits of a multidisciplinary team
More informationTHE VALVE CLINIC VALVE CONFERENCE
VALVE CLINIC THE VALVE CLINIC Houston Methodist DeBakey Valve Clinic combines outstanding clinical care, advanced imaging and surgical excellence to offer coordinated evaluation and treatment options for
More information2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)
2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationHardware in the Chest - From VADs to Valves
Hardware in the Chest - From VADs to Valves Cristina Fuss, MD Purpose Recognize the device Indication and function Cristina Fuss, MD Department of Diagnostic Radiology FROM VADS TO VALVES Implanting technique
More informationLate failure of transcatheter heart valves: An open question
Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement
More informationTranscatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD
Transcatheter Therapies For Aortic Valve Disease March 2017 Brian Whisenant MD Introduction I got into this field to protect my turf. I must say, I have come full circle... - Kent W. Jones I got into this
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Measure #445 (NQF 0119): Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationDESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft
Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS
More informationMeasure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care
Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationAortic Valve Stenosis and TAVR: Putting it all together.
Aortic Valve Stenosis and TAVR: Putting it all together. Maria L. Held, MSN CNS Valve Clinic Coordinator at The Cleveland Clinic Alliance of Cardiovascular Professionals April 14 th, 2018 Brief Anatomy
More informationQuality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
More informationSurgeon Involvement in Transcatheter Valve Therapy
Surgeon Involvement in Transcatheter Valve Therapy Prof. Hendrik Treede Mid-German Heartcenter University Hospital Halle (Saale) Once upon a time. classic interventional cardiology classic cardiac surgery
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic
More informationMINIMALLY INVASIVE MITRAL VALVE SURGERY. Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems
MINIMALLY INVASIVE MITRAL VALVE SURGERY Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems OVERVIEW History Anatomy Indications Techniques Variants Outcomes &
More information2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR
TRANSCATHETER AORTIC VALVE REPLACEMENT IN 2018: IS IT NOW THE STANDARD OF CARE? 22 ND ANNUAL COASTAL CARDIAC & VASCULAR CONFERENCE FEBRUARY 17, 2018 R. David Anderson, MD, MS, FACC, FSCAI Professor of
More informationQuality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care
Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationMitral Valve Surgery: Lessons from New York State
Mitral Valve Surgery: Lessons from New York State Joanna Chikwe, MD Professor of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai Chairman & Program Director Department of Cardiovascular
More informationNext Generation Therapies: Aortic, Mitral and Beyond
Next Generation Therapies: Aortic, Mitral and Beyond Scott M Lilly, MD PhD Medical (Interventional) Director, Structural Heart Program Heart Summit, Lima OH August 26 th, 2017 Next Generation Therapies:
More informationTAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion
TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion Moderator: Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular
More informationTAVR and Cardiac Surgeons
TAVR and Cardiac Surgeons TAVR and Cardiac Surgeons Ragheb Hasan Consultant and Clinical Lead Cardiothoracic Surgeon Manchester Royal Infirmary, Oxford Road, Manchester UK Aortic Stenosis Is A Growing
More informationDebate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI
Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular Surgery University of Pennsylvania Immediate
More informationAppropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.
Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y. Szeto, MD on behalf of The PARTNER Trial Investigators and The PARTNER
More informationPercutaneous Transapical Access for Thoracic Endovascular Repair
Percutaneous Transapical Access for Thoracic Endovascular Repair Atman P. Shah MD FACC FSCAI Co-Director, Hans Hecht Cardiac Catheterization Laboratory Clinical Director, Section of Cardiology Associate
More informationTAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?
TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular
More informationUnderstanding the guidelines for Interventions in MR. Ali AlMasood
Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationMeasure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationmm Porcine valve Patient had requested
Mrs CY Age 77 History 2000:Age 60: MVR 27mm St Jude Valve (severe MR) 2015:Age 75: Paravalvular mitral leak, haemolytic anaemia, tricuspid incompetence. 27mm Porcine valve and 29mm Duran ring tricuspid
More informationStrokes After TAVR Reasons for Declining Frequency
Strokes After TAVR Reasons for Declining Frequency Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Disclosure NONE Second Generation Valves Newer
More informationIs TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients
Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Cedars Sinai Heart Institute, Los Angeles, CA Potential
More informationAlec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France
Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationCulprit vs Multivalve Transcatheter Intervention
Culprit vs Multivalve Transcatheter Intervention Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology
More information7 th Conference of Transcatheter Heart Valve Therapies
7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationIs a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?
Interactive CardioVascular and Thoracic Surgery Advance Access published May 7, 2012 Interactive CardioVascular and Thoracic Surgery 0 (2012) 1 5 doi:10.1093/icvts/ivr141 BEST EVIDENCE TOPIC Is a minimally
More informationValvular heart disease (VHD) is present in 2.5% of the
2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations Richard Matiasz, MD; Vera H. Rigolin, MD Valvular heart disease (VHD) is present in 2.5% of the
More informationSelection of aortic valve replacement versus transcatheter aortic valve replacement in high-risk patients: a Markov model
Selection of aortic valve replacement versus transcatheter aortic valve replacement in high-risk patients: a Markov model Hemal Gada, MD, MBA and Thomas H Marwick, MD, PhD Department of Cardiovascular
More informationTAVR Transaortic Approach: New Trends in Aortic Valve Surgery
: New Trends in Aortic Valve Surgery Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Director, Center for Diseases of the Thoracic Aorta Washington University School of
More informationCardiac Valve/Structural Therapies
Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,
More informationValvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University.
Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD Director Cath Labs, Washington Hospital Center. ProfessorofMedicine (Cardiology), Georgetown University. Conflict of Interest Proctor
More informationTranscatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis
More informationTAVR in 2020: What is Next!!!!
TAVR in 2020: What is Next!!!! Vinod H. Thourani, MD Professor of Surgery Chairman, Department of Cardiac Surgery Medstar Heart and Vascular Institute Washington Hospital Center Washington, DC Disclosures
More informationACTION REGISTRY New Old ID# ID #
In Process, Unpublished NCDR Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript development, or
More informationTranscatheter Aortic Valve Replacement TAVR
Transcatheter Aortic Valve Replacement TAVR Paul Gordon, MD Associate Prof of Medicine, Brown University Director, Cardiac Catheterization Laboratory The Miriam Hospital Disclosures: none 100 Symptomatic
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationIgor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School
Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of
More informationAPOLLO TMVR Trial Update: Case Presentation
APOLLO TMVR Trial Update: Case Presentation Anelechi Anyanwu, MD, MSc, FRCS-CTh Professor and Vice-Chairman Department of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai New York, NY Disclosure
More informationIs it a business for the cardiac surgeon?
TAVI FOR LOW RISK PATIENTS Is it a business for the cardiac surgeon? Augusto D Onofrio Gino Gerosa Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy T A V I Cardiac surgery
More informationTAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology
TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for
More informationNew Paradigms in Thoracic. Accommodate Advances in Cardiovascular Surgical Therapy. A.J. Carpenter, MD, PhD Professor of Thoracic Surgery
New Paradigms in Thoracic Surgical Training to Accommodate Advances in Cardiovascular Surgical Therapy A.J. Carpenter, MD, PhD Professor of Thoracic Surgery University i of ftexas Health hscience Center,
More informationQuality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care
Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome
More informationWhat is the Role of Surgical Repair in 2012
What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationPresent State of Therapeutic Strategies for Thoracic Surgical Diseases in Japan
From the Japanese Association of Medical Sciences The Japanese Association for Thoracic Surgery Present State of Therapeutic Strategies for Thoracic Surgical Diseases in Japan JMAJ 52(2): 117 121, 2009
More informationParticipating Hospitals & Publicly Released COAP Data
Participating Hospitals & Publicly Released COAP Data Welcome to the hospital outcomes section of the Clinical Outcomes Assessment Program (COAP) web site where you can find detailed information on the
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationYOUR CARDIOTHORACIC SURGERY TEAM
JAMES R. TAYLOR, JR., MD, Co-Director, Stony Brook Heart Institute; Chief, Division of Cardiothoracic Surgery and Professor of Surgery, is board certified in cardiothoracic and general surgery, and has
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationTranscatheter Heart Valve. Replacement. With the Edwards SAPIEN 3. for Patients & Caregivers
For Patients With a Failing Surgical Bioprosthetic Heart Valve Transcatheter Heart Valve Replacement With the Edwards SAPIEN 3 Transcatheter Heart Valve for Patients & Caregivers This patient booklet is
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationCleveland Clinic Innovation Center
Innovations Cleveland Clinic Innovation Center Cleveland Clinic Innovation Center (CCIC) is Cleveland Clinic s technology commercialization arm. Our mission is to benefit the sick through the broad and
More informationMeasuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France
Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France Faculty disclosure Bernard Iung I disclose the following financial relationships: Consultant
More informationParticipating Hospitals & Publicly Released COAP Data
Participating Hospitals & Publicly Released COAP Data Welcome to the hospital outcomes section of the Clinical Outcomes Assessment Program (COAP) web site where you can find detailed information on the
More informationIncorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)
Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine
More informationAortic Stenosis: Background
Transcatheter Aortic Valve Replacement in Low Surgical Risk Patients Barry George, MD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Aortic Stenosis: Background Severe Symptomatic
More informationSurgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan
Surgical AF Ablation : Lesion Sets and Energy Sources What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Disclosures Consultant/Advisory Board: Abbott, Edwards Lifesciences
More informationWhen Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea
When Should We Consider TAVI Procedure in Korea (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea Aortic Stenosis in Korea Rapidly increasing valve disease in Korea Still low incidence
More informationEssential Support for a Structural Heart Program: The Valve and Structural Heart Clinic
Essential Support for a Structural Heart Program: The Valve and Structural Heart Clinic Vincent Varghese, DO, FACC, FSCAI Director, Interventional Cardiology Fellowship Program Deborah Heart and Lung Center
More informationShould We Reconsider using Anticoagulation for Biological Tissue Valves
Should We Reconsider using Anticoagulation for Biological Tissue Valves No Disclosures Disclosures Watching grass grow Complete with audio 1 hour 8 minutes 9884 views Subclinical Leaflet Thrombosis in
More informationUpdate on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center
Update on Percutaneous Therapies for Structural Heart Disease William Thomas MD Director of Structural Heart Program Tucson Medical Center NCVH 2014- Tucson Disclosure of Financial Interest Research: Stock
More informationAn Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.
An Update on the Edwards TAVR Results Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St. Luke s Hospital Disclosures On the speaker s bureau for Endologix, TriVascular,
More informationTranscatheter Mitral Valve for fmr: The Era of Too Many Options
Transcatheter Mitral Valve for fmr: The Era of Too Many Options Isaac George, M.D. Surgical Director, Structural Heart & Valve Center Assistant Professor of Surgery Columbia University Medical Center Disclosure
More informationCardiac surgery and acute kidney injury: retrospective study
Cardiac surgery and acute kidney injury: retrospective study Department of Cardiovascular and Thoracic Surgery University of Liege Hospital (ULg CHU), Belgium MG LAGNY 1, F BLAFFART 1, JO DEFRAIGNE 2,
More informationOutcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John
More informationEvolving and Expanding Indications for TAVR
Evolving and Expanding Indications for TAVR Wilson Y. Szeto, MD Associate Professor of Surgery Surgical Director, Transcatheter Cardio-Aortic Therapies Associate Director, Thoracic Aortic Surgery Division
More information